Mid-Day Market Update: Gold Rises Over 1%; Harpoon Therapeutics Shares Plummet
Midway through trading Friday, the Dow traded up 0.39% to 34,713.33 while the NASDAQ rose 1.28% to 13,789.21. The S&P also rose, gaining 0.69% to 4,221.95.
40 Stocks Moving In Friday’s Mid-Day Session
Gainers
SemiLEDs Corporation (NASDAQ: LEDS) shares jumped 68.8% to $25.49 after gaining 23% on Thursday.
Ashford Hospitality’s Stock Breaks Through Resistance: What’s Next?
Ashford Hospitality Trust Inc. (NYSE: AHT) is trading higher Friday morning as retail traders have been able to continue to push the stock up.
3 Penny Stocks To Consider For The Oil Rally
As oil continues to soar and approaches $70 a barrel, shares of many stocks in the energy sector have rallied as well. Some appear to be poised to keep moving higher.
Cyclerion Out-Licenses Praliciguat to Akebia, Announces $18M Capital Raise
Cyclerion Therapeutics Inc (NASDAQ:CYCN) has entered into an exclusive, global license agreement with Akebia Therapeutics Inc (NASDAQ:AKBA) for the development and commercialization of…
Surface Oncology’s SRF388 Shows Promising Anticancer Activity in Pretreated Patients
Surface Oncology (NASDAQ:SURF) has announced new data from the ongoing Phase 1 studies of SRF388 and SRF617. SRF388 data will be…
Mid-Morning Market Update: Markets Open Higher; US Economy Adds 559,000 Jobs in May
Following the market opening Friday, the Dow traded up 0.26% to 34,666.18 while the NASDAQ rose 1.22% to 13,780.27. The S&P also rose, gaining 0.64% to 4,219.82.
Surface Oncology, Roche Team Up to Develop SRF388 Combo Therapy for Liver Cancer
Surface Oncology (NASDAQ:SURF) has entered into a clinical trial collaboration with Roche Holdings AG (OTC:RHHBY) to evaluate former’s SRF388, anti-IL-27 antibody, in combination…
Coherus, Junshi Toripalimab-Chemo Combo Beat Chemo Alone in Late-Stage Nose & Throat Cancer Trial
Shanghai Junshi Biosciences Co Ltd and Coherus BioSciences Inc (NASDAQ:CHRS) have announced positive results from the pivotal Phase 3 JUPITER-02 trial evaluating toripalimab…
The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 3)